Showing results (431-440 of 561) with videos related to
Sort By:
Pageof 57
Nature|November 8, 1984
The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a proteinJ A Tainer, E D Getzoff, H Alexander, et al.Science (New York, N.Y.)|January 31, 2015
Protein structure. Structure and activity of tryptophan-rich TSPO proteinsYouzhong Guo, Ravi C Kalathur, Qun Liu, et al.Iucrj|July 19, 2019
Synchrotron microcrystal native-SAD phasing at a low energyGongrui Guo, Ping Zhu, Martin R Fuchs, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient miceS L Epstein, C Y Lo, J A Misplon, et al.Virology|September 5, 2003
Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognitionMarkus Koch, Marie Pancera, Peter D Kwong, et al.Plos One|February 25, 2010
Mechanistic issues of the interaction of the hairpin-forming domain of tBid with mitochondrial cardiolipinFrançois Gonzalvez, Fabrizio Pariselli, Olivier Jalmar, et al.Blood|August 15, 1990
High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myelomaB Barlogie, S Jagannath, D O Dixon, et al.Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 bindingH Wu, D G Myszka, S W Tendian, et al.Equine Veterinary Journal|February 4, 2010
Concurrent or sequential development of medial meniscal and subchondral cystic lesions within the medial femorotibial joint in horses (1996-2006)S M Hendrix, G M Baxter, C W McIlwraith, et al.Therapeutic Innovation & Regulatory Science|March 23, 2021
Aggregate Safety Assessment Planning for the Drug Development Life-CycleBarbara A Hendrickson, William Wang, Greg Ball, et al.Pageof 57